Form 4: BridgeBio Pharma COO Thomas Trimarchi Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Thomas Trimarchi, President and COO of BridgeBio Pharma, disposed of 17,936 shares of common stock to satisfy tax obligations related to vesting restricted stock units.
Summary
- On August 16, 2024, Thomas Trimarchi, the President and COO of BridgeBio Pharma, disposed of 17,936 shares of the company's common stock.
- The transaction was executed to cover the reporting person's tax obligations associated with the vesting of 32,431 shares of common stock underlying restricted stock units.
- The shares were disposed of at a price of $24.4.
- Following the transaction, Trimarchi directly owns 395,923 shares of BridgeBio Pharma.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction to cover tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. This filing indicates a transaction related to tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 08/16/2024 | Date of transaction: Disposal of shares to cover tax obligations. |
| 08/20/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.